Oncology Institute (DFPH) Total Current Liabilities (2019 - 2026)

Oncology Institute (DFPH) has 8 years of Total Current Liabilities data on file, last reported at $79.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 33.27% year-over-year to $79.4 million; the trailing twelve-month figure through Mar 2026 stood at $79.4 million (up 33.27% YoY), and the FY2025 full-year result was $71.0 million, up 35.9% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $79.4 million, up from $71.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $79.4 million in Q1 2026 and bottomed at $29.7 million in Q4 2022.
• The 5-year median for Total Current Liabilities is $36.1 million (2022), against an average of $45.9 million.
• The widest annual swing landed in 2022, when Total Current Liabilities soared 18271.88%; it then slipped 7.26% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $29.7 million in 2022, then climbed by 17.05% to $34.8 million in 2023, then surged by 50.09% to $52.2 million in 2024, then soared by 35.9% to $71.0 million in 2025, then climbed by 11.82% to $79.4 million in 2026.
• The last three Total Current Liabilities figures came in at $79.4 million (Q1 2026), $71.0 million (Q4 2025), and $65.6 million (Q3 2025), per Business Quant data.

Peer Comparison